News

Ormat Energizes the Market with 20MW Montague Storage Facility

Ormat Energizes the Market with 20MW Montague Storage Facility

Ormat Technology's New Energy Storage Milestone

Ormat Technologies Inc. (NYSE: ORA), a prominent player in the geothermal and renewable energy sector, has reached an exciting new milestone by commencing commercial operations for its Montague energy storage facility. This state-of-the-art facility, boasting a capacity of 20MW and 120MWh, is set to enhance the PJM market by providing essential ancillary services.

Significance of the Montague Energy Storage Facility

The Montague facility's successful launch signifies Ormat's continued dedication to expanding its footprint in the energy storage market. This project, which qualifies for a substantial 30% Investment Tax Credit, further bolsters Ormat's energy storage capabilities, bringing its total capacity in the PJM market to 120MW/120MWh.

CEO’s Vision for Ormat's Energy Storage Growth

Doron Blachar, the CEO of Ormat Technologies, expressed pride in launching the Montague facility, which is a testament to the company’s enduring commitment to growth in strategic U.S. markets. Currently, Ormat operates 290MW and 658MWh of energy storage projects, demonstrating a robust expansion strategy. With several initiatives in development, Ormat aims to achieve a remarkable portfolio target of 950MW to 1050MW by the year 2028. This focus on growth reflects Ormat's ambition to enhance profitability while meeting rising energy demands.

Impact on Energy Reliability and Transition to Clean Energy

Blachar emphasized that the Montague project is crucial for providing reliable ancillary services, which are vital for the stability of the grid. This facility plays an essential role in facilitating the transition towards a cleaner energy future, showcasing Ormat's dedication to sustainable energy solutions that support the broader markets.

About Ormat Technologies

With a legacy spanning over five decades, Ormat Technologies stands at the forefront of the geothermal industry. It is uniquely positioned as a vertically integrated company dealing in geothermal and recovered energy generation. The firm is aggressively pursuing growth opportunities in the energy storage sector, aiming to establish a commanding presence within the U.S. market.

Ormat is not just a geothermal powerhouse; it also excels in designing and manufacturing energy solutions. The company has developed an impressive portfolio, totaling approximately 3,400MW in gross capacity worldwide, primarily employing the innovative Ormat Energy Converter, which transforms varying heat sources into electricity.

Diverse Energy Portfolio Drivers

Ormat's current generation portfolio includes 1,520MW, of which 1,230MW consists of geothermal and solar generation projects spread across numerous countries including the U.S., Kenya, Guatemala, Indonesia, Honduras, and Guadeloupe. This extensive reach enables Ormat to play a critical role in diversifying and enhancing global energy supplies.

Commitment to Future Growth

The company is seeing significant potential in integrating energy storage with solar photovoltaic (PV) solutions. This positions Ormat well as demand grows for reliable and renewable energy resources, vital for a sustainable future.

Frequently Asked Questions

What is the capacity of the Montague energy storage facility?

The Montague energy storage facility has a capacity of 20MW and 120MWh.

What market does the Montague facility serve?

The facility provides ancillary services to the PJM market, which plays a significant role in electricity supply in the U.S.

How does the Montague facility support renewable energy?

The facility enhances grid reliability by providing necessary services that support the integration of renewable energy sources.

What is Ormat’s future energy storage target?

Ormat aims to expand its energy storage portfolio to between 950MW and 1050MW by 2028.

How long has Ormat been in the energy sector?

Ormat Technologies has over five decades of experience in geothermal and renewable energy technologies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading